-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Vincerx Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2024.
- Vincerx Pharma, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$8.83M, a 59.5% decline year-over-year.
- Vincerx Pharma, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$31.5M, a 26.2% increase year-over-year.
- Vincerx Pharma, Inc. annual Operating Income (Loss) for 2024 was -$31.5M, a 26.2% increase from 2023.
- Vincerx Pharma, Inc. annual Operating Income (Loss) for 2023 was -$42.6M, a 40.1% increase from 2022.
- Vincerx Pharma, Inc. annual Operating Income (Loss) for 2022 was -$71.2M, a 13.6% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)